Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of a Novel Titania Nanoparticle-Reinforced Bonding Agent in Reducing Post-Restorative Sensitivity: A Randomized Clinical Trial

NCT05744648 is registered in ClinicalTrials.gov with Pakistan Institute of Medical Sciences as lead sponsor.

NCT NCT05744648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05744648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of a Novel Titania Nanoparticle-Reinforced Bonding Agent in Reducing Post-Restorative Sensitivity: A Randomized Clinical Trial
Lead sponsor
Pakistan Institute of Medical Sciences
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2023
Completion date
June 20, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carious lesion